Univariate analysis of medical conditions associated with major bleeding
| Medical condition . | Odds ratio (95% CI) . | P value . |
|---|---|---|
| IF | 8.59 (2.57-28.70) | .003 |
| Infection | 4.12 (1.46-11.59) | .01 |
| In the hospital at the time of thrombosis | 5.77 (1.30-25.61) | .01 |
| Central line causing thrombosis (at first thrombosis) | 2.49 (0.89-6.94) | .12 |
| Congenital thrombophilia | NA | .15 |
| IBD | 1.99 (0.25-15.79) | .42 |
| Anatomic abnormality | 2.21 (0.29-16.93) | .71 |
| Cancer at the time of thrombosis | 1.55 (0.35-6.89) | .75 |
| Antiphospholipid syndrome | NA | 1.0 |
| Surgery (within 6 weeks of thrombotic event) | 1.05 (0.33-3.35) | 1.0 |
| Systemic lupus erythematosus | NA | 1.0 |
| Number of comorbidities (mean, SD) | NA | .24 |
| Medical condition . | Odds ratio (95% CI) . | P value . |
|---|---|---|
| IF | 8.59 (2.57-28.70) | .003 |
| Infection | 4.12 (1.46-11.59) | .01 |
| In the hospital at the time of thrombosis | 5.77 (1.30-25.61) | .01 |
| Central line causing thrombosis (at first thrombosis) | 2.49 (0.89-6.94) | .12 |
| Congenital thrombophilia | NA | .15 |
| IBD | 1.99 (0.25-15.79) | .42 |
| Anatomic abnormality | 2.21 (0.29-16.93) | .71 |
| Cancer at the time of thrombosis | 1.55 (0.35-6.89) | .75 |
| Antiphospholipid syndrome | NA | 1.0 |
| Surgery (within 6 weeks of thrombotic event) | 1.05 (0.33-3.35) | 1.0 |
| Systemic lupus erythematosus | NA | 1.0 |
| Number of comorbidities (mean, SD) | NA | .24 |
Patients without a bleed (n = 616) are compared to patients with a bleed (n = 16).
NA, not applicable; SD, standard deviation.